Literature DB >> 29798930

High-Quality Draft Genome Sequence of Sphaerisporangium cinnabarinum ATCC 31213.

Line Friis Bakmann Christensen1, Daniel Otzen1, Morten Simonsen Dueholm2.   

Abstract

A high-quality draft genome sequence of Sphaerisporangium cinnabarinum ATCC 31213 is presented here. This bacterium produces several important bioactive compounds and may also produce functional amyloids. This is the first sequenced genome from the genus Sphaerisporangium, and it will be essential in determining the nature of the potential amyloid protein.
Copyright © 2018 Christensen et al.

Entities:  

Year:  2018        PMID: 29798930      PMCID: PMC5968725          DOI: 10.1128/genomeA.00456-18

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Members of the genus Sphaerisporangium are aerobic Gram-positive bacteria that form mycelia and spherical sporangia (1). They are primarily found in soils (2, 3), often in association with the rhizosphere (4–7). Many members of the genus produce bioactive secondary metabolites (8–12) and can also be used for the biotransformation of antimicrobials (13). Sphaerisporangium cinnabarinum (previously referred to as Streptosporangium cinnabarinum) strain ATCC 31213 was originally isolated in 1977 from soil in the Philippines and was shown to produce two different antibiotics effective against strains of Staphylococcus aureus, Mycobacterium smegmatis, and Bacillus subtilis (14). Another antibiotic produced by S. cinnabarinum, the secondary metabolite GE82832, specifically inhibits translation in bacteria (10–12). S. cinnabarinum also produces 1-hydroxy-4-methoxy-2-naphthoic acid, which is an effective herbicide against the freshwater plant Lemna minor (15). Recently, S. cinnabarinum was proposed to form functional amyloids, as the mycelia showed strong binding to conformation-specific antibodies that recognize a generic amyloid fibril epitope (16, 17). Further studies of S. cinnabarinum, including identification of the proposed amyloid protein and identification of pathways for antibiotic synthesis, would benefit from this genome announcement. Genomic DNA was isolated using a FastDNA spin kit (MP Biomedicals). A paired-end library was prepared with the NEBNext Ultra II DNA library prep kit for Illumina (New England BioLabs). All procedures were carried out as recommended by the manufacturer. Sequencing of the libraries was performed using a MiSeq sequencer (Illumina, Germany). The paired-end reads were trimmed for adapters and quality using the built-in tool of CLC Genomics Workbench version 9.5.5 (Qiagen, USA). The genome was de novo assembled from the paired-end data in CLC Genomics Workbench using the default settings. The average coverage of the assembly was 60×. Annotation was done using the NCBI Prokaryotic Genome Automatic Annotation Pipeline (PGAAP) (18). The draft genome sequence of S. cinnabarinum strain ATCC 31213 is composed of 134 contigs and has a predicted size of ∼4.39 Mbp. The overall G+C content is 74.7%. Annotation by the NCBI PGAAP identified 3,988 coding sequences (CDSs), as well as 3 rRNA (5S, 16S, or 23S) and 51 tRNA genes.

Accession number(s).

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. QAPD00000000. The version described in this paper is the first version, QAPD01000000.
  16 in total

1.  Biosynthetic potential of phylogenetically unique endophytic actinomycetes from tropical plants.

Authors:  Jeffrey E Janso; Guy T Carter
Journal:  Appl Environ Microbiol       Date:  2010-05-14       Impact factor: 4.792

2.  Characterization of GE82832, a peptide inhibitor of translocation interacting with bacterial 30S ribosomal subunits.

Authors:  Letizia Brandi; Attilio Fabbretti; Michele Di Stefano; Ameriga Lazzarini; Monica Abbondi; Claudio O Gualerzi
Journal:  RNA       Date:  2006-05-12       Impact factor: 4.942

3.  1-Hydroxy-4-methoxy-2-naphthoic acid, a herbicidal compound produced by Streptosporangium cinnabarinum ATCC 31,213.

Authors:  C Pfefferle; J Breinholt; H Gürtler; H P Fiedler
Journal:  J Antibiot (Tokyo)       Date:  1997-12       Impact factor: 2.649

4.  MBJ-0086 and MBJ-0087, new bicyclic depsipeptides, from Sphaerisporangium sp. 33226.

Authors:  Teppei Kawahara; Masashi Itoh; Miho Izumikawa; Junko Hashimoto; Noriaki Sakata; Toshio Tsuchida; Kazuo Shin-ya
Journal:  J Antibiot (Tokyo)       Date:  2014-08-06       Impact factor: 2.649

5.  Sphaerisporangium corydalis sp. nov., isolated from the root of Corydalis yanhusuo L.

Authors:  Xin Wang; Chongxi Liu; Jiaxu Cheng; Yuejing Zhang; Zhaoxu Ma; Lianjie Li; Xiangjing Wang; Wensheng Xiang
Journal:  Antonie Van Leeuwenhoek       Date:  2015-05-12       Impact factor: 2.271

6.  Sphaerisporangium dianthi sp. nov., an endophytic actinomycete isolated from a root of Dianthus chinensis L.

Authors:  Jia Xing; Chongxi Liu; Yuejing Zhang; Hairong He; Ying Zhou; Lianjie Li; Junwei Zhao; Shuanghe Liu; Xiangjing Wang; Wensheng Xiang
Journal:  Antonie Van Leeuwenhoek       Date:  2014-10-08       Impact factor: 2.271

7.  Sphaerisporangium siamense sp. nov., an actinomycete isolated from rubber-tree rhizospheric soil.

Authors:  Kannika Duangmal; Ratchanee Mingma; Wasu Pathom-Aree; Yuki Inahashi; Atsuko Matsumoto; Arinthip Thamchaipenet; Yoko Takahashi
Journal:  J Antibiot (Tokyo)       Date:  2011-03-16       Impact factor: 2.649

8.  Structural and functional characterization of the bacterial translocation inhibitor GE82832.

Authors:  Letizia Brandi; Sonia Maffioli; Stefano Donadio; Fabio Quaglia; Marco Sette; Pohl Milón; Claudio O Gualerzi; Attilio Fabbretti
Journal:  FEBS Lett       Date:  2012-07-24       Impact factor: 4.124

9.  Sphaerisporangium rufum sp. nov., an endophytic actinomycete from roots of Oryza sativa L.

Authors:  Ratchanee Mingma; Kannika Duangmal; Savitr Trakulnaleamsai; Arinthip Thamchaipenet; Atsuko Matsumoto; Yoko Takahashi
Journal:  Int J Syst Evol Microbiol       Date:  2013-12-20       Impact factor: 2.747

10.  The antibiotics dityromycin and GE82832 bind protein S12 and block EF-G-catalyzed translocation.

Authors:  David Bulkley; Letizia Brandi; Yury S Polikanov; Attilio Fabbretti; Michael O'Connor; Claudio O Gualerzi; Thomas A Steitz
Journal:  Cell Rep       Date:  2014-01-09       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.